SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 77 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $219,000 | -89.2% | 75,701 | -83.3% | 0.00% | -80.0% |
| Q2 2017 | $2,022,000 | +4.6% | 454,343 | +9.5% | 0.01% | 0.0% |
| Q1 2017 | $1,934,000 | +2969.8% | 415,021 | +3381.7% | 0.01% | – |
| Q3 2015 | $63,000 | -41.1% | 11,920 | -7.9% | 0.00% | – |
| Q2 2015 | $107,000 | +44.6% | 12,942 | -18.7% | 0.00% | – |
| Q1 2015 | $74,000 | +57.4% | 15,926 | +4.0% | 0.00% | – |
| Q4 2014 | $47,000 | +46.9% | 15,310 | +31.6% | 0.00% | – |
| Q3 2014 | $32,000 | -64.4% | 11,631 | -47.6% | 0.00% | – |
| Q2 2014 | $90,000 | -28.0% | 22,182 | -5.8% | 0.00% | – |
| Q1 2014 | $125,000 | +5.9% | 23,543 | +11.7% | 0.00% | – |
| Q4 2013 | $118,000 | +49.4% | 21,075 | +21.0% | 0.00% | – |
| Q3 2013 | $79,000 | +16.2% | 17,423 | +10.2% | 0.00% | – |
| Q2 2013 | $68,000 | – | 15,816 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Partners USVI, LLC | 152,500 | $697,000 | 2.61% |
| Trellus Management Company, LLC | 155,800 | $712,000 | 0.90% |
| WALL STREET ASSOCIATES | 942,200 | $4,306,000 | 0.40% |
| BAILARD, INC. | 340,500 | $1,556,000 | 0.30% |
| Baker Brothers Advisors | 2,608,271 | $11,920,000 | 0.17% |
| STONERIDGE INVESTMENT PARTNERS LLC | 104,158 | $476,000 | 0.10% |
| Cambridge Investment Research Advisors, Inc. | 449,080 | $2,052,000 | 0.09% |
| BTG Pactual Global Asset Management Ltd | 33,700 | $154,000 | 0.03% |
| HighTower Advisors, LLC | 242,001 | $1,106,000 | 0.03% |
| BHF Kleinwort Benson Group S.A. | 39,000 | $178,000 | 0.02% |